Venus Remedies Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight

Circuit Event and Unfilled Supply

The stock, trading in the EQ series, hit its lower circuit price band of 5%, closing at Rs 835.95 after touching an intraday low of Rs 824.85. This price band capped the maximum daily loss allowed, effectively freezing trading at the floor price. The total traded volume was 25,980 shares, with a turnover of Rs 2.20 crore. Despite this turnover, the presence of unfilled supply was evident as sellers queued at the lower circuit price with no buyers stepping in to absorb the selling pressure. This scenario is typical in micro-cap stocks like Venus Remedies Ltd, where liquidity constraints amplify exit difficulties. How deep is the exit problem for Venus Remedies and what would need to change for normal trading to resume?

Delivery and Volume Analysis

Delivery volumes on 20 Mar 2026 stood at 23,560 shares, marking a decline of 27.5% against the 5-day average delivery volume. This fall in delivery volume during a lower circuit day suggests that the selling pressure may be partly driven by speculative short-selling rather than widespread liquidation by holders. On lower circuit days, rising delivery volumes typically indicate genuine dumping of holdings, but here the reduced delivery volume points to a more nuanced selling pattern. The total traded volume was relatively low, consistent with the mechanical effect of the circuit breaker limiting price movement and thus suppressing turnover. Is this decline in delivery volume a sign of speculative shorts or a temporary pause in holder capitulation?

Intraday Price Action

The stock opened near its high of Rs 873.00 but steadily declined throughout the session, closing near the circuit low of Rs 824.85. This intraday range of Rs 48.15 represents a 5.5% swing, slightly exceeding the 5% price band due to the opening price being above the previous close. The weighted average price indicates that more volume traded closer to the low price, reinforcing the narrative of persistent selling pressure that pushed the stock down to the circuit floor. The gradual descent rather than a sudden gap-down suggests sellers were active throughout the day, but buyers remained absent, allowing the circuit breaker to intervene and halt further decline.

Moving Averages and Trend Context

Technically, Venus Remedies Ltd trades below its 5-day moving average but remains above the 20-day, 50-day, 100-day, and 200-day moving averages. This mixed moving average configuration indicates short-term weakness but some underlying medium- to long-term support remains intact. The dip below the 5-day average confirms recent selling momentum, but the stock has not yet broken through the more significant longer-term moving averages that often act as support levels. Does the technical profile of Venus Remedies show any nearby support, or is more downside likely?

Liquidity and Exit Risk

With a market capitalisation of approximately Rs 1,157 crore, Venus Remedies Ltd is classified as a micro-cap stock. The liquidity profile is moderate, with the stock liquid enough for a trade size of Rs 0.09 crore based on 2% of the 5-day average traded value. However, the lower circuit event highlights the exit risk inherent in micro-cap stocks — sellers face significant challenges exiting positions when demand dries up, as evidenced by the unfilled supply at the circuit floor. This illiquidity can prolong circuit locks over multiple sessions, compounding the difficulty for holders seeking to liquidate. How severe is the liquidity exit risk for Venus Remedies and what might ease this pressure?

Fundamental Context

Operating within the Pharmaceuticals & Biotechnology sector, Venus Remedies Ltd is positioned in a competitive industry that has seen sector-wide declines of 3.07% on the day, underperforming the Sensex’s 2.57% fall. The stock’s 3.72% loss on the day slightly underperformed its sector, reflecting company-specific pressures rather than broad market weakness. This micro-cap’s valuation and fundamentals remain subject to typical sector volatility and liquidity constraints.

Conclusion: Severity and Liquidity Caveats

The 5% lower circuit lock for Venus Remedies Ltd underscores a session dominated by persistent selling and a lack of buying interest. The decline in delivery volume suggests speculative short-selling rather than widespread holder capitulation, but the unfilled supply at the circuit floor highlights the liquidity challenges faced by micro-cap stocks. The stock’s position below the 5-day moving average confirms short-term weakness, while the broader moving averages offer some technical support. Given the micro-cap status and moderate liquidity, the exit risk remains a significant concern, with sellers potentially trapped until demand re-emerges. After a 5% single-day loss at lower circuit, is Venus Remedies approaching oversold territory or does the selling pressure have further to run? The complete analysis weighs the data.